.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Find suppliers and generic API sources

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Colorcon
Deloitte
Farmers Insurance
Chinese Patent Office
UBS
Fish and Richardson
Queensland Health
Johnson and Johnson
Baxter

Generated: July 25, 2017

DrugPatentWatch Database Preview

Emd Serono Company Profile

« Back to Dashboard

What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?

EMD SERONO has thirteen approved drugs.

There are five US patents protecting EMD SERONO drugs.

There are one hundred and two patent family members on EMD SERONO drugs in thirty-nine countries.

Summary for Applicant: Emd Serono

Patents:5
Tradenames:13
Ingredients:8
NDAs:13
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS020378-003May 25, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
SEROSTIM
somatropin recombinant
INJECTABLE;INJECTION020604-002Aug 23, 1996BXRXNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
ZORBTIVE
somatropin recombinant
INJECTABLE;INJECTION021597-003Dec 1, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd Serono
NOVANTRONE
mitoxantrone hydrochloride
INJECTABLE;INJECTION019297-003Dec 23, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021765-001Mar 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Emd Serono

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono
GONAL-F RFF REDI-JECT
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021684-001May 25, 2004► Subscribe► Subscribe
Emd Serono Inc
GEREF
sermorelin acetate
INJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd Serono
GONAL-F RFF REDI-JECT
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021684-001May 25, 2004► Subscribe► Subscribe
Emd Serono
LUVERIS
lutropin alfa
INJECTABLE;SUBCUTANEOUS021322-001Oct 8, 2004► Subscribe► Subscribe
Emd Serono
GONAL-F
follitropin alfa/beta
INJECTABLE;SUBCUTANEOUS021765-001Mar 25, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Emd Serono Drugs

Country Document Number Estimated Expiration
Austria308990► Subscribe
Colombia5090905► Subscribe
Czech Republic301912► Subscribe
Norway20005145► Subscribe
European Patent Office1610822► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Emd Serono Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
9C0031Belgium► SubscribePRODUCT NAME: ACETATE DE CETRORELIX; REGISTRATION NO/DATE: EU/1/99/100/001 19990413
C/GB10/022United Kingdom► SubscribePRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125
01C/020Belgium► SubscribePRODUCT NAME: LUTROPINE ALFA; REGISTRATION NO/DATE: EU/1/00/155/001 20001129
90029Netherlands► SubscribePRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413
C0024France► SubscribePRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Moodys
Cipla
Fuji
McKinsey
Harvard Business School
UBS
Novartis
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot